Calvin Knowlton
Chair of the Board of Directors @American Foundation For Pharmaceutical Education
Signup · Get unlimited contacts
WORK HISTORY
Chair of the Board of Directors @American Foundation For Pharmaceutical Education
Washington, DC, US
EDUCATION
University of Maryland, Baltimore (UMB)
Doctor of Science (Hon) - ScD
Temple University School of Pharmacy
BS Pharm
Princeton Theological Seminary
Master of Divinity - MDiv, Theology/Theological Studies
University of Maryland, Baltimore (UMB)
Doctor of Philosophy - PhD, Pharmacoeconomics/Pharmaceutical Economics
ABOUT CALVIN KNOWLTON
Dr. Calvin Knowlton is a highly educated healthcare executive with years of experience working in the pharmaceutical industry. He is a serial entrepreneur who has launched ten successful ventures, each dedicated to helping improve patient outcomes by supplying pharmacists with helpful resources and technology. Dr. Calvin\'s work has focused on pharmacogenomics, pharmacokinetics, and other concepts that can help prescribers minimize negative drug interactions and provide patients with the best possible treatment plan. Some of Dr. Calvin\'s most successful ventures have been Hospice Pharmacia (later renamed to excelleRX) and Tabula Rasa Healthcare. Currently, he is living in Amelia Island, FL, and working on his latest venture: Spyglass Healthcare, LLC.Dr. Calvin Knowlton was Chairperson and CEO of Tabula Rasa HealthCare (TRHC), which is the first national medication risk mitigation™ company. Since its founding in 2009, TRHC has become the leader in providing patient-specific, data-driven technology and solutions that enable pharmacists to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and prolong life. Documentation of these outcomes produced by pharmacists using TRHC’s proprietary MedWise platform can be found here. He took TRHC public in September 2016 (NASDAQ: TRHC). The Company now employees >1,700 team members, with more than 400 Board Certified PharmDs and revenue >$300mln. This was the 10th company he has led.Prior to TRHC, he was Chairperson and CEO of Hospice Pharmacia / excelleRx, which grew to $250mln revenue, and served >800 hospices programs and hospice patients nationwide with medication management solutions. It was sold to Omnicare in 2005 for $269mln. It is now owned by Humana.His board service includes Chair of the Board of the Evergreens Continuing Care Retirement Community; Founding board member of the Cooper Medical School of Rowan University; Member of the boards for The Coriell Institute for Medical Research, Coriell Life Sciences, St Christopher’s Hospital for Children, the Settlement Music School, Samaritan Hospice & Palliative Care, Chair of Spyglass II Condominium Association in Amelia Island, and Chair of the board of BKON, a start-up company in Moorestown, NJ.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.